DNA Replication Licensing and Cell Cycle Kinetics in Breast Cancer
Author Information
Author(s): Shetty A, Loddo M, Fanshawe T, Prevost A T, Sainsbury R, Williams G H, Stoeber K
Primary Institution: University College London
Hypothesis
The study investigates whether the deregulation of DNA replication licensing factors occurs during mammary carcinogenesis and their potential as prognostic markers.
Conclusion
The study found that high-level MCM expression in poorly differentiated breast tumors limits their utility as prognostic markers.
Supporting Evidence
- Increasing tumor grade is associated with increased expression of Ki67, Mcm2, and geminin.
- The Mcm2/Ki67 ratio decreases with increasing tumor grade, indicating a shift from a licensed to a proliferating state.
- Ki67, Mcm2, and the Mcm2/Ki67 ratio are significantly associated with the Nottingham Prognostic Index.
Takeaway
This study looks at how certain proteins involved in DNA copying behave in normal and cancerous breast tissue, helping us understand breast cancer better.
Methodology
Protein expression profiles were generated for various markers in normal and breast cancer specimens, and compared to clinicopathological parameters.
Limitations
Only 12% of the variation in the Nottingham Prognostic Index is explained by Mcm2, indicating limited prognostic utility.
Participant Demographics
The study included 120 breast cancer specimens and 18 normal breast tissue samples from women undergoing reduction mammoplasty.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website